Skip to main content

Michael Dugan

Clinical Genomics has appointed Michael Dugan as its chief medical officer. Dugan previously served as president and CEO of MCDXI Medical Diagnostics, where he led clinical evaluation, strategic development and clinical education efforts for companies bringing diagnostic tests and related products to market. Before that, he was also senior vice president of clinical development and medical affairs at Exact Sciences, medical director at Quest Diagnostics' Nichols Institute, and vice president and laboratory director at Specialty Laboratories.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.